Table 3.
Central tumor sample | Peripheral tumor sample | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
N | Mean | Min | Max | p value | N | Mean | Min | Max | p value | |
CD8 + average | ||||||||||
FHOD1 neg/weak | 40 | 53.5 | 2.7 | 168.5 | 0.039 | 19 | 42.5 | 2.1 | 103.5 | 0.003 |
FHOD1 interm/high | 143 | 71.7 | 0.8 | 345.6 | 132 | 71.7 | 0.9 | 402.0 | ||
CD3 + average | ||||||||||
FHOD1 neg/weak | 40 | 85.9 | 15.2 | 257.3 | 0.090 | 19 | 70.8 | 4.0 | 171.4 | 0.216 |
FHOD1 interm/high | 143 | 104.9 | 2.5 | 429.9 | 132 | 96.4 | 4.0 | 508.0 | ||
FOXP3 average | ||||||||||
FHOD1 neg/weak | 40 | 25.1 | 2.0 | 83.0 | 0.614 | 19 | 22.5 | 0.2 | 104.8 | 0.708 |
FHOD1 interm/high | 143 | 27.2 | 0.3 | 116.7 | 133 | 24.9 | 0.3 | 123.0 |
Statistically significant p values are indicated in bold